Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (FRX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Wright Reports
|
$449.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Sanford Wittels & Heisler Files $100 Million Gender Discrimination Class Action Against Forest Laboratories Inc
Sanford Wittels & Heisler, LLP, announced that it has filed a $100 million gender discrimination lawsuit against New York-based Forest Laboratories, Inc. and Forest Pharmaceuticals, Inc., in the U.S. District Court for the Southern District of New York. Forest Pharmaceuticals is a wholly owned subsidiary of Forest Laboratories.
Latest Developments for Forest Laboratories Inc
- Forest Laboratories Inc's CEO Solomon To Step Down At Year End-Reuters
- Almirall SA and Forest Laboratories Inc Announces Positive Phase III Combo Results from its Second Study for Aclidinium and Formoterol
- Forest Laboratories Inc Issues FY 2014 Guidance; Revenue Guidance Below Analysts' Estimates
- Almirall SA And Forest Laboratories Inc Announces Positive Phase III Study Results For Aclidinium And Formoterol Combination In COPD
- Share this
- Link this
- Digg this
Follow Reuters